scholarly journals Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis

2021 ◽  
Author(s):  
Akimichi Morita ◽  
Yukari Okubo ◽  
Yoji Morisaki ◽  
Hitoe Torisu-Itakura ◽  
Yoshinori Umezawa
Keyword(s):  
Japanese Patients ◽  
Pustular Psoriasis ◽  
Generalized Pustular Psoriasis ◽  
Erythrodermic Psoriasis

Novel IL36RN gene mutation revealed by analysis of 8 Japanese patients with generalized pustular psoriasis

2014 ◽  
Vol 76 (3) ◽  
pp. 267-269 ◽  
Author(s):  
Mitsuha Hayashi ◽  
Tsuguhisa Nakayama ◽  
Tomomitsu Hirota ◽  
Hidehisa Saeki ◽  
Yoshimasa Nobeyama ◽  
...  
Keyword(s):  
Gene Mutation ◽  
Japanese Patients ◽  
Pustular Psoriasis ◽  
Generalized Pustular Psoriasis

Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis

2017 ◽  
Vol 31 (9) ◽  
pp. e420-e421 ◽  
Author(s):  
C. Mugheddu ◽  
L. Atzori ◽  
A. Lappi ◽  
M. Pau ◽  
S. Murgia ◽  
...  
Keyword(s):  
Pustular Psoriasis ◽  
Generalized Pustular Psoriasis ◽  
Erythrodermic Psoriasis

scholarly journals Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study

2018 ◽  
Vol 45 (12) ◽  
pp. 1371-1380 ◽  
Author(s):  
Akimichi Morita ◽  
Fumikazu Yamazaki ◽  
Takashi Matsuyama ◽  
Kenzo Takahashi ◽  
Satoru Arai ◽  
...  
Keyword(s):  
Japanese Patients ◽  
Pustular Psoriasis ◽  
Open Label ◽  
Phase 3 ◽  
Generalized Pustular Psoriasis ◽  
Open Label Phase ◽  
Adalimumab Treatment
Sign in / Sign up

Export Citation Format

Share Document